博士論文

The combination of HLA-B[*]15:01 and DRB1[*]15:01 is associated with gemcitabine plus erlotinib induced-interstitial lung disease in patients with advanced pancreatic cancer

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Available in National Diet Library

Find on the publisher's website

国立国会図書館デジタルコレクション

The combination of HLA-B[*]15:01 and DRB1[*]15:01 is associated with gemcitabine plus erlotinib induced-interstitial lung disease in patients with advanced pancreatic cancer

Persistent ID (NDL)
info:ndljp/pid/10312014
Material type
博士論文
Author
西村, 明子
Publisher
西村, 明子
Publication date
2016
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
神戸大学,博士(医学)
View All

Notes on use at the National Diet Library

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
The combination of HLA-B[*]15:01 and DRB1[*]15:01 is associated with gemcitabine plus erlotinib induced-interstitial lung disease in patients with advanced pancreatic cancer
Author/Editor
西村, 明子
Publication, Distribution, etc.
西村, 明子
Publication Date
2016
Publication Date (W3CDTF)
2016
Alternative Title
進行膵癌患者におけるゲムシタビンとエルロチニブによる間質性肺疾患に対するHLA-B[*]15:01とDRB1[*]15:01の組み合わせの関連
Degree grantor/type
神戸大学
Date Granted
2016-03-25
Date Granted (W3CDTF)
2016-03-25